Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Furoscix® (furosemide) – Expanded indication
August 12, 2024 - scPharmaceuticals announced the FDA approval of Furoscix (furosemide), for the treatment of congestion due to fluid overload in adult patients with chronic heart failure.
